RediTrex
- Product NDC
- 69605-817
- 11-digit product format
- 696050817
- Labeler code
- 69605
- Product ID
- 69605-817_d4506622-932a-fec8-e053-2a95a90afa41
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methotrexate
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- CENEXI - BLA
- Application
- NDA210737
- Marketing category
- NDA
- Marketing start
- 2020-07-01
- Marketing end
- 0000-00-00
- Substance
- METHOTREXATE
- Active strength
- 18 mg/.7mL
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69605-817-22 | 69605081722 | 4 CARTON in 1 CASE (69605-817-22) > 1 SYRINGE in 1 CARTON (69605-817-11) > .7 mL in 1 SYRINGE | 4 carton | 2020-07-01 | 0000-00-00 | No | No | Current |